Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4625871000168112 | Deferasirox (Teva) (deferasirox 360 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4625881000168110 | Deferasirox (Teva) 360 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Deferasirox (Teva) 360 mg tablet | Is a | deferasirox 360 mg tablet | true | Inferred relationship | Some | ||
| Deferasirox (Teva) 360 mg tablet | Is a | Deferasirox (Teva) | true | Inferred relationship | Some | ||
| Deferasirox (Teva) 360 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Deferasirox (Teva) 360 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Deferasirox (Teva) 360 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1834087884 | |
| Deferasirox (Teva) 360 mg tablet | has intended active ingredient | deferasirox | true | Inferred relationship | Some | 1139051951 | |
| Deferasirox (Teva) 360 mg tablet | has Australian BoSS | deferasirox | true | Inferred relationship | Some | 1139051951 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Deferasirox (Teva) 360 mg tablet, 30, blister pack | has TPUU | True | Deferasirox (Teva) 360 mg tablet | Inferred relationship | Some | 780300854 |
| Deferasirox (Teva) 360 mg tablet, 30 | has TPUU | True | Deferasirox (Teva) 360 mg tablet | Inferred relationship | Some | 1906056939 |
Reference Sets
Trade product unit of use reference set
FHIR